NOTCH1 and neoplasm: Notably, using orthotopic model of cSCC, Katarkar and colleagues have shown that genetic silencing or pharmacological inhibition of NOTCH1 in CAFs suppressed orthotopic cSCC tumor growth, suggesting that NOTCH1 in the CAF compartment of the tumor stroma is a potentially useful target for stroma-centered anti-cSCC therapy (186).